A new study presented at the 2017 Heart Rhythm Scientific Sessions examined whether continued use of previously ineffective antiarrhythmic therapy lowered the risk of recurrence within a year of ablation.
...
A new study presented at the 2017 Heart Rhythm Scientific Sessions examined whether continued use of previously ineffective antiarrhythmic therapy lowered the risk of recurrence within a year of ablation.
...
A recent study examined the efficacy of an experimental cholesteryl ester transfer protein inhibitor for lowering major adverse cardiovascular events in patients with high-risk vascular disease.
In a recent study, researchers examined outcomes in patients with atrial fibrillation taking aspirin, including risk of cerebrovascular events and gastrointestinal bleeding.
Past research has suggested an association between the use of statins and an increased risk of developing back disorders, including spondylosis and intervertebral disc disorders.
